A Vathsala
Overview
Explore the profile of A Vathsala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yang F, Griva K, Lau T, Vathsala A, Lee E, Ng H, et al.
Qual Life Res
. 2015 Mar;
24(9):2163-71.
PMID: 25800727
Background: This study aimed to identify factors associated with the health-related quality of life (HRQOL) of multiethnic Asian end-stage renal disease (ESRD) patients treated with dialysis. The role of dialysis...
12.
Yang F, Lau T, Lee E, Vathsala A, Chia K, Luo N
Eur J Health Econ
. 2014 Dec;
16(9):1019-26.
PMID: 25519850
Objectives: The objective of this study was to compare the performance of the 5-level EuroQol 5-dimension (EQ-5D-5L) and the Short Form 6-dimension (SF-6D) instruments in assessing patients with end-stage renal...
13.
Lee V, Tiong H, Vathsala A, Madhavan K
Transplant Proc
. 2014 Aug;
46(6):2019-22.
PMID: 25131097
Introduction: Vascular thrombosis is an important cause of pancreatic graft loss, and the vast majority is managed using graft pancreatectomy. There are limited reports and case series of successful salvage...
14.
Goh Y, Cheong P, Lata R, Goh A, Vathsala A, Li M, et al.
Transplant Proc
. 2014 Mar;
46(2):310-3.
PMID: 24655950
Donor safety is of paramount importance in addressing end-stage renal failure through living kidney transplantation. The United States Food and Drug Administration (FDA) issued a Class II recall on the...
15.
Goh A, Oei E, Vathsala A
Transplant Proc
. 2012 Feb;
44(1):193-9.
PMID: 22310613
A positive T-cell cross-match is a well-established contraindication to deceased donor renal transplantation (DDRT); however, the significance of a positive B-cell cross-match (BCXM) remains debatable. Thus, given the high demand...
16.
Teo B, Sau P, Xu H, Ma V, Vathsala A, Lee E
Nephron Clin Pract
. 2010 Dec;
118(2):c86-92.
PMID: 21150216
Introduction: Clinical practice guidelines recommend empiric antibiotic therapy for suspected tunnelled haemodialysis catheter-related infections (CRI), and the choice of antibiotics should be adjusted according to the local microbiological profile and...
17.
Goh A, Vathsala A
Am J Transplant
. 2010 Oct;
11(1):86-92.
PMID: 20973916
Urinary tract cancers are the third most common cancers in renal transplant recipients (RTX). This study examined the impact of dialysis duration and native renal cyst(s) (NRC) on renal cell...
18.
Ong K, Teo M, Lee V, Ong D, Lee A, Tan C, et al.
Clin Cancer Res
. 2009 Aug;
15(17):5350-8.
PMID: 19706821
Purpose: EBV-positive smooth muscle tumor (EBV+SMT) is a rare disease with no established therapy. We describe the largest single institution analysis in renal transplant recipients. It aims to define its...
19.
Woo K, Chan C, Tan H, Choong H, Foo M, Vathsala A, et al.
Clin Nephrol
. 2009 May;
71(6):617-24.
PMID: 19473629
Aim: Several short-term studies have reported the efficacy of high-dose ARB in reducing proteinuria in patients with diabetic nephropathy. The benefits of long-term high-dose ARB losartan in IgA nephritis have...
20.
Vathsala A, Chow K
Ann Acad Med Singap
. 2009 May;
38(4):291-9.
PMID: 19434331
Introduction: Renal transplantation is the best treatment for kidney failure. As the demand far exceeds the supply, various legislative measures have been put into place in Singapore to increase kidney...